Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Aspirin Stories

2011-12-10 10:00:00

SAN DIEGO, Dec.10, 2011 /PRNewswire-USNewswire/ -- Bleeding and clotting disorders affect a large number of patients annually and, while accurate diagnosis is important, timely and effective treatment for these disorders is key, as they have the potential to quickly become life-threatening. Research examining novel treatment techniques for bleeding and clotting disorders will be presented today at the 53rd Annual Meeting of the American Society of Hematology. Bleeding disorders,...

2011-11-29 07:30:00

HAYWARD, Calif., Nov. 29, 2011 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that its arhalofenate program has been recognized in Windhover's "Top 10 most interesting cardiovascular/metabolic diseases projects to watch." Arhalofenate is a potential best-in-class treatment for gout that not only treats the hyperuricemia that causes gout, but also addresses...

Taking Aspirin For Heart Health Not Worth The Risk For Women: Study
2011-11-29 06:25:25

Taking aspirin to ward off strokes or heart attacks is not worth the risk for healthy, middle-aged women, according to a new Dutch study published in the European Heart Journal. The researchers said that 50 women would need to take the medication for 10 years for just one to be helped - assuming they were all at high risk in the first place. "There are very few women who actually benefit," said the study´s lead author, Dr. Jannick Dorresteijn of University Medical Center Utrecht in...

Most Hospitalizations Among Seniors Due To Four Drug Types
2011-11-26 05:39:35

Four types of drugs are responsible for the majority of hospitalizations of older Americans each year, a new Centers for Disease Control and Prevention (CDC) study has discovered. Among U.S. residents aged 65 and older, there are a total of 100,000 drug-related emergency hospitalizations each year, and two-thirds of them result from the blood thinner warfarin, insulin, oral anti-platelets such as aspirin, and oral diabetes drugs, lead researcher and CDC Medication Safety Program Director...

2011-11-23 11:33:25

Repeatedly taking slightly too much paracetamol over time can cause a dangerous overdose that is difficult to spot, but puts the person at danger of dying. Patients may not come to hospital reporting the overdose, but because they feel unwell. This clinical situation needs to be recognized and treated rapidly because these patients are at even greater danger than people who take single overdoses. These so-called staggered overdoses can occur when people have pain and repeatedly take a...

2011-11-22 17:26:52

Researchers at King's College London have discovered how one of the most common household painkillers works, which could pave the way for less harmful pain relief medications to be developed in the future Researchers at King's College London have discovered how one of the most common household painkillers works, which could pave the way for less harmful pain relief medications to be developed in the future. Paracetamol, often known in the US and Asia as acetaminophen, is a widely-used...

2011-11-16 09:35:43

In a contemporary cohort of acute heart attack patients, 70 percent of the patients were unaware they had coronary heart disease (CHD) prior to the event and 60 percent of those patients were women or young men. However, these two subgroups are less likely to qualify for aggressive preventive therapy and, therefore, do not receive preventive medications that could reduce the heart attack risk, according to a study being presented at the American Heart Association (AHA) scientific sessions in...

2011-11-14 22:28:32

BIDMC researcher says improvement in survival rates best 'since introduction of aspirin' An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions. The results were also published online by the New England Journal of Medicine. The drug, rivaroxaban, proved effective in preventing the...

2011-11-13 07:00:00

ORLANDO, Fla., Nov. 13, 2011 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that adding oral rivaroxaban to standard antiplatelet therapy significantly reduced the composite primary efficacy endpoint of cardiovascular-related deaths, heart attacks or strokes in patients with acute coronary syndrome (ACS) compared to those receiving standard therapy alone. Results from the pivotal Phase 3 ATLAS ACS 2 TIMI 51 trial presented today at...

2011-11-09 22:33:32

Patients with acute coronary syndrome and/or diabetes who show poor response to dual antiplatelet therapy as measured by platelet function testing are at greater risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents The relationship of platelet responsiveness to antiplatelet medications; and, the correlation of poor response, and overall platelet aggregation while on dual antiplatelet therapy to the risk of drug-eluting stent thrombosis after 30 days...